Exhibitors, partners and supporters

The 2024 ABPI Conference is sponsored by and partnered with the following organisations

ABPI Conference Logos 0015 Appnovation


Appnovation is a global digital partner that delivers business impact today and drives the digital future for our clients. Our commitment to building digital solutions is rooted in a customer-first approach, ensuring long-lasting value.

ABPI Conference Logos 0008 Digital Control Room

Digital Control Room

Digital Control Room helps pharma to maintain compliance of its digital content once it has been published online.  Our platform automatically and regularly scans a company’s entire web estate looking for incorrect, out-of-date, or potentially problematic content at a forensic level of detail.

ABPI Conference Logos 0007 Ethos


Ethos, a company specialising in education and behaviour change in the field of pharmaceutical ethics and compliance with the ABPI and EFPIA Codes. We create engaging, accessible learning delivered both live and online that empowers learners to make ethical and compliant business decisions.

We have education designed for final signatories, creators and reviewers, field force teams, allied agencies, and those in support functions. Our mission is simple – to equip learners to make sound decisions in the patient and business interest. When done right, it is a fascinating topic to learn, discuss and debate.

ABPI Conference Logos 0018 Pharmareview


PharmaReview, an IQVIA business, provides copy review services to the life science industry, in the UK, in the EMEA region and globally.

Copy review is an important, yet time-consuming job for thousands of professionals. We ensure materials, whether internal or external, promotional or non-promotional, are ready for rapid progression to distribution.

ABPI Conference Logos 0006 Herbert Smith Freehills

Herbert Smith Freehills

At Herbert Smith Freehills, we believe that helping your business starts with understanding your perspective. As one of the world's pre-eminent law firms, we have a track record of advising leading pharmaceutical, life sciences and biomedical companies on their most important matters.

Bringing together scientifically qualified specialist legal advisors with the platform and resources of a global firm, our team provides cutting-edge, sector-focused insight, advising on strategic transactions and disputes, antitrust and regulatory investigations, commercial contracts, licensing and patent litigation. Drawing on decades of sector focus, tapping into our 24-office global network and fielding renowned teams, we help our clients develop, commercialise and protect their innovations globally.

ABPI Conference Logos 0014 AWTTC

All Wales Therapeutics and Toxicology Centre (AWTTC)

The All Wales Therapeutics and Toxicology Centre (AWTTC) is an NHS organisation that delivers a range of services which support the best use of medicines to help patients in Wales be healthier and better-informed.

Our multi-disciplinary team work on health technology assessments; medicines optimisation, medicines safety and toxicology; and analysing prescribing data.

We work with patients, carers and patient organisations; healthcare professionals; the pharmaceutical industry; Welsh Government and UK organisations to produce guidance on the best use of medicines and to make sure patients in Wales receive appropriate care.

The Yellow Card Centre (Wales) is part of AWTTC and we encourage patients, carers and all healthcare professionals to report suspected adverse reactions to medications and vaccines via the UK Yellow Card Scheme.

If you’d like to get in touch please email awttc@wales.nhs.uk or visit our website awttc.nhs.wales

ABPI Conference Logos 0003 MOIC

Medicines Optimisation Innovation Centre (MOIC)

The Medicines Optimisation Innovation Centre (MOIC) is a regional centre in Northern Ireland dedicated to driving innovation in medicines use through research, innovation, quality improvement and knowledge transfer. MOIC seeks to contribute to the success of the Northern Ireland economy through the development, testing, scale and spread of medicines optimisation expertise and technologies across the world.

MOIC key themes:

Focus on the needs of the Northern Ireland population
Accelerate the adoption of innovation into practice to improve clinical outcomes and patient experience
Build a culture of partnership and collaboration
Make a meaningful contribution to the Northern Ireland economy.
Partnership, Collaboration and Engagement

MOIC seeks new solutions to address gaps in best practice which are developed and tested prior to commissioning for scale-up and implementation regionally. Utilising the ‘quadruple helix’, MOIC collaborates across civil society, academia, healthcare and industry and establishes commercial and non-commercial partnerships.

Patients are the at the heart of everything we do. We were joined by a number of patient charity organisations.

ABPI Conference Logos 0018 Age UK

Age UK

Age UK is the UK’s leading charity supporting older people most in need.

Our vision is a world where every older person feels valued and included. We provide information, advice, friendship and support for older people, their families, friends and communities – and seek to change public attitudes by campaigning to drive societal and systemic change for older people nationally, locally and internationally.

Asthma + Lung UK

Asthma + Lung UK is the lung health charity fighting for everyone’s right to breathe. 

Why we’re fighting for breath

In the UK, respiratory care simply isn’t good enough.

Even before Covid-19, NHS hospital admissions for lung conditions were rising three times faster than average admissions.

Lung disease is now the third most common cause of death, costing the NHS more than £11 billion every year. So this issue needs to be at the top of the health agenda.

People living with lung conditions are often overlooked and being left behind. Their condition isn’t accurately diagnosed at an early stage – and even when they are diagnosed, they’re not given the care they need.

We fund cutting-edge research, and provide advice and support for the 12 million people who will get a lung condition during their lifetime. We also campaign for clean air and better NHS diagnosis and treatment.

Because breath is life – and it’s worth fighting for.

ABPI Conference Logos 0017 Asthma Lung UK
ABPI Conference Logos 0016 Anthony Nolan

Anthony Nolan

We are Anthony Nolan. We are pioneers in transforming the lives of those needing stem cell transplants across the globe. We have half a century of experience and expertise in saving lives:

  • By making lifesaving connections between patients and incredible strangers, ready to donate their stem cells
  • By funding ground-breaking research that could transform the future for more patients
  • By providing the best experience for every patient before, during and after transplant

But we’re still learning, still growing, and still pushing the boundaries through new cell therapies and treatments. Everyday Anthony Nolan gives four people a second chance of life, but we know there is so much more that can be done and we’re ambitious about doing it. We believe in a future where every patient who needs us can survive and thrive.

Survival: We want to give every transplant patient the best chance - and quality - of life

Equity: We want to ensure every patient has the best access to, experience of and outcomes from treatment

Progress: We want to explore and embrace new cell therapies and make them available for patients more quickly 

Blood Cancer Alliance

There are around 240,000 people living with blood cancer in the UK. Together, blood cancers are the fifth most common type of adult cancer, the most common cancer amongst children and the third most fatal cancer. Those living with blood cancer face unique challenges whilst undergoing diagnosis, treatment and on-going care.

The Blood Cancer Alliance is a group of fifteen UK charities. We are working to tackle the issues blood cancer patients face and improve the experience and outcomes of all those living with blood cancer.

We believe that equal priority in UK policymaking must be given to cancers, like blood cancer, that are more difficult to diagnose and rarely have surgical options for treatment. It is our collective ambition to see progress in the following areas:

Reducing delays to diagnosis: The number of blood cancer patients who had to see their GP five or more times before being referred to a specialist is more than double that of patients with other cancers. Around 30% of blood cancer patients are diagnosed in an emergency setting, when their cancer is likely to have progressed. Blood cancer patients deserve specific strategies to address this issue.

Improving access to innovative treatment: With few surgical treatment options available for blood cancer, innovation in treatment is critical to reducing mortality. However, there are significant challenges within the current UK model for adopting new treatments into the NHS.

Addressing inequality in care and experience: Blood cancer patients should have access to fair, equitable treatment, and the NHS must ensure national policies and health service design takes account of their specific and complex needs. However, from awareness, to diagnosis, to information, care and support, blood cancer patients are less likely to see their needs fully met than patients with the four most commons cancers.

ABPI Conference Logos 0013 Blood Cancer Alliance
ABPI Conference Logos 0012 Blood Cancer UK

Blood Cancer UK

Blood Cancer UK is the UK's largest blood cancer charity. Our aim is to bring forward the day when every single person affected by blood cancer can live a full life. 

We are a community dedicated to beating blood cancer by funding research and supporting those affected. Since 1960, we've invested over £500 million in blood cancer research, transforming treatments and saving lives. 

We do this by funding research into all types of blood cancer –including leukaemia, lymphoma and myeloma – at leading institutions across the UK. The day we will beat blood cancer is now in sight and our researchers are determined to finish the job. 

As well as looking for a cure in the future, we also provide high quality information and support services. We’re here for people when they need someone to talk to. Whether on the phone or online, we offer health information people can trust, in a language they can understand. 

We also campaign for change, helping to make sure that people get the healthcare they deserve and that new treatments that come from research breakthroughs are available on the NHS. 

We put people affected by blood cancer at the heart of everything we do. 

British Heart Foundation

Heart attacks that strike without warning, strokes that shatter futures, newborn babies born with broken hearts. These are just some of the cruelties of cardiovascular disease. And the brutal reality is, there is so much more for science to discover before we can beat the world's biggest killers.

That's why British Heart Foundation exists. Funding research is how we beat cardiovascular disease. And we all have a role to play. The tools we have at our disposal today—from heart transplants and pacemakers to stents and portable defibrillators—are all down to research. Research is vital, and BHF currently fund the majority (52%) of all non-commercially funded research into heart and circulatory diseases, with our aim to find breakthroughs and to improve outcomes.

Our research has helped halve the number of people dying annually from these conditions since the 1960s—back then, more than seven out of ten heart attacks in the UK were fatal. Today, more than seven out of ten people survive. But there is still more work to be done, and we are always striving to find more breakthroughs so that people and families across the UK will have better chances and healthier lives.

ABPI Conference Logos 0011 British Heart Foundation
ABPI Conference Logos 0010 Cancer52


Cancer52 represents over 110 predominantly small patient support group cancer charities united by their vision of seeing a better future for everyone affected by the rare and less common cancers, which account for more than half of all cancer deaths in the UK.

Our aim is to promote improved diagnosis, treatment and support for those affected by rare and less common cancers. Cancer52 works on matters that impact on the rare and less common cancer community – defined as all cancers outside the ‘big four’ of breast, prostate, lung and bowel.

Crohn's & Colitis

There are no two ways about it: a diagnosis of Crohn’s or Colitis is life changing. Here at Crohn’s & Colitis UK, we all know it, as does everyone affected by these devastating conditions. 

The problem is, not everyone else knows it. 

These chronic conditions are painful, debilitating and widely misunderstood. There is no known cure. Our mission starts now, to bring about Better Diagnosis, Better Care and Better Lives for the 500,000+ people living with the conditions in the UK. 

We are leading the fight against Crohn’s and Colitis. With your help, we’re going to change people’s lives for the better. The condition is life-changing, but so are our supporters. 

We are Crohn’s & Colitis UK. 

A national charity supporting everyone affected by Crohn’s Disease, Ulcerative Colitis and other forms of Inflammatory Bowel Disease (IBD). 

We exist to achieve a better quality of life for those affected, while fighting for earlier diagnosis, driving increased research funding and, ultimately, finding a cure.

In the UK, over half a million people are living with Crohn’s and Colitis. So that’s half a million reasons to join forces and help us demand better. We build strategic, impactful and mutually beneficial corporate partnerships to better support communities and people in need. 

Our partners are a crucial part of what comes next. We’ll work together not only to empower those living with the diseases, but also to have a significant impact on your business and employees too. 

Help us to lead the fight and be part of changing half a million lives for the better.

ABPI Conference Logos 0004 Crohn's & Colitis UK
ABPI Conference Logos 0009 Cystic Fibrosis Trust

Cystic Fibrosis Trust

The Cystic Fibrosis Trust is the only UK-wide charity dedicated to uniting for a life unlimited for everyone affected by cystic fibrosis. We fund vital research, improve care, speak out and race towards effective treatments for all. We won't stop until everyone with cystic fibrosis can live without limits. The Trust provides confidential advice, support, and information on any aspect of cystic fibrosis, including help with financial support. The work the Trust does is only made possible by the generous donations from supporters. Visit www.cysticfibrosis.org.uk to find out more about cystic fibrosis, the work of the Trust and how you can help.

The Clinical Trials Accelerator Platform (CTAP) was launched in 2017 in collaboration with the USA Cystic Fibrosis Foundation and is managed by the Cystic Fibrosis Trust. CTAP is a UK wide initiative bringing together Cystic Fibrosis (CF) Centres from around the UK to support delivery of CF clinical trials. CTAP provides the infrastructure to support sponsors with the delivery of CF clinical trials (commercial and academic), and the platform to enable the CF community to gain access to these trials. More information about CTAP can be found here: https://www.cysticfibrosis.org.uk/the-work-we-do/clinical-trials-accelerator-platform

The Cystic Fibrosis Trust also sponsors and manages The UK Cystic Fibrosis Registry. It is a secure centralised database that records health data on consenting people with cystic fibrosis (CF) in England, Wales, Scotland and Northern Ireland https://www.cysticfibrosis.org.uk/the-work-we-do/uk-cf-registry

Kidney Research UK

For more than 60 years the research we fund has been making an impact.

But kidney disease is increasing. It is estimated that estimates there are 7.2 million people in the UK are currently living with chronic kidney disease, more than 10% of the entire population.  Factors contributing to kidney disease are also growing, such as diabetes, cardiovascular disease and obesity, and people with kidney disease are also at increased risk of heart attack or stroke.

At Kidney Research UK we work with clinicians and scientists across the UK, funding and facilitating research into all areas of kidney disease. We collaborate with partners across the public, private and third sectors to prevent kidney disease and drive innovation to transform treatments.
Over the last ten years we have invested more than £58 million into research. We lobby governments and decision makers to change policy and practice to ensure that more than 3 million people living with kidney disease in the UK have access to the most effective care and treatment, and to make kidney disease a priority.

Most importantly, we also work closely with patients, ensuring their voice is heard and is at the centre of everything we do, from deciding which research to invest in to how we plan our priorities and our work across the charity. Those patient contributions are vital, always helping us and our partners to understand what life is like with kidney disease, always ensuring we see the patient behind the treatment and always reminding us that behind every statistic and every number is a person – the patients and the carers who inspire our mission and push us forward to make a difference and change the future of kidney disease. 

ABPI Conference Logos 0005 Kidney Research UK

Oracle Cancer Trust

Oracle Cancer Trust is the leading Head and Neck cancers charity in the UK, and our vision is to ensure everyone has the best chance of surviving Head and Neck cancers. With your support we will do this by enabling greater awareness, knowledge and understanding of Head and Neck cancers. 

Our mission is to improve Head and Neck Cancer patient quality of life and outcomes

The number of new head and neck cancer cases on average each year in the UK is projected to rise from around 14,000 cases in 2023-2025 to around 16,300 cases in 2038-2040. By 2027 Oracle will have made visible impact on the RACE against the crisis in Head and Neck cancers:

  • Research projects that we have funded will provide more understanding about these cancers, how best to treat them and where the greatest unmet needs are;
  • Awareness campaigns around Head and Neck cancers, their symptoms and prevention measures;
  • Collaboration programmes that promotes knowledge sharing and improvebest practice;
  • Experience and care pathway support becoming more accessible and visible for patients of all backgrounds.
ABPI Conference Logos 0002 Oracle
ABPI Conference Logos 0001 Prostate Cancer Research

Prostate Cancer Research

Prostate Cancer Research is a research and information provision charity that is dedicated to improving and saving the lives of people with prostate cancer.

We are focused on three key programmes of work:

(1) academic and social research funding, focused on achieving breakthroughs in the prevention, diagnosis and treatment of advanced prostate cancer, and better quality of life outcomes for patients;

(2) translational research through Proven Connect which is focused on ensuring more promising treatments get from laboratory to patient through bridging the gap between industry, investors, health providers and patients; and

(3) patient information and empowerment that enables marginalised and traditionally underrepresented people living with prostate cancer to play a more active role in driving forward changes in research, treatment and care.

Sickle Cell Society

The Sickle Cell Society is the only national charity in the UK that supports and represents people affected by a sickle cell disorder to improve their overall quality of life.

First set up as a registered charity in 1979, the Sickle Cell Society has been working alongside health care professionals, parents, and people living with sickle cell to raise awareness of the disorder. The Society’s aim is to support those living with sickle cell, empowering them to achieve their full potential. 

The Sickle Cell Society believes that individuals with sickle cell have the right to quality care. This can only be achieved if funding is made available to educate health carers and other professionals about the condition. The Society aims to provide this.
The Society does not discriminate between the types of sickle cell disorders or the ethnic groups concerned. Both sexes are equally affected, and should have equal access to support and services within a confidential and sensitive environment. We respect the views of every patient. 

We have a network of committed volunteers, who play an important part in running the charity, providing administrative backup, and helping with fund-raising activities. 

Donations from the public and fundraising activities are also part of our life support. Without them, we would be unable to finance the essential research and educational projects and we would be unable to offer children a much-needed summer retreat. The Society benefits from the support of a wide range of individuals and organisations nationally, who together play a vital role in its success.

ABPI Conference Logos 0000 Sickle Cell

Last modified: 23 May 2024

Last reviewed: 23 May 2024